Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR vs IR Cognitive Function in Schizophrenia
NCT01213836Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, sponsored by AstraZeneca. Started Nov 2010; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01213836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213836.